Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions.

Stromal dynamic reciprocity (SDR) consists of the biophysical and biochemical interplay between connective tissue elements that regulate and maintain organ homeostasis. In epithelial cancers, chronic alterations of SDR result in the once tumor-restrictive stroma evolving into a 'new' tumor-permissive environment. This altered stroma, known as desmoplasia, is initiated and maintained by cancer associated fibroblasts (CAFs) that remodel the extracellular matrix (ECM). Desmoplasia fuels a vicious cycle of stromal dissemination enriching both CAFs and desmoplastic ECM. Targeting specific drivers of desmoplasia, such as CAFs, either enhances or halts tumor growth and progression. These conflicting effects suggest that stromal interactions are not fully understood. This review highlights known fibroblastic-ECM interactions in an effort to encourage therapies that will restore cancer-restrictive stromal cues.

[1]  Richard O. Hynes,et al.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[2]  Kati Räsänen,et al.  Activation of fibroblasts in cancer stroma. , 2010, Experimental cell research.

[3]  Zhang Weidong,et al.  Clinicopathological Significance of Stromal Myofibroblasts in Invasive Ductal Carcinoma of the Breast , 2004, Tumor Biology.

[4]  Robert A. Weinberg,et al.  Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type , 2006, Cell cycle.

[5]  E. Cukierman,et al.  Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts. , 2005, The American journal of pathology.

[6]  S. Estrem,et al.  Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway , 2015, Drug design, development and therapy.

[7]  William C Hines,et al.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.

[8]  M. Glogauer,et al.  Transforming growth factor-beta induction of alpha-smooth muscle actin is dependent on the deformability of the collagen matrix. , 1999, Current topics in pathology. Ergebnisse der Pathologie.

[9]  R. Wells.  The role of matrix stiffness in regulating cell behavior , 2008, Hepatology.

[10]  Derek S. Chan,et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.

[11]  K. Devarajan,et al.  Elevated Expression of Stromal Palladin Predicts Poor Clinical Outcome in Renal Cell Carcinoma , 2011, PloS one.

[12]  Jun Yao,et al.  Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.

[13]  M. Mullendore,et al.  An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer , 2008, Molecular Cancer Therapeutics.

[14]  D. Weaver,et al.  Higher Stromal Expression of Transforming Growth Factor-beta Type II Receptors is Associated with Poorer Prognosis Breast Tumors , 2003, Breast Cancer Research and Treatment.

[15]  G. Gabbiani,et al.  Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. , 2001, Journal of cell science.

[16]  E. Cukierman,et al.  FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells , 2011, BMC Cancer.

[17]  T. Barker,et al.  Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. , 2012, American journal of respiratory cell and molecular biology.

[18]  Z. Werb,et al.  Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. , 1998, Science.

[19]  Klaus Schulten,et al.  A structural model for force regulated integrin binding to fibronectin's RGD-synergy site. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[20]  David J Mooney,et al.  Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. , 2014, Nature materials.

[21]  H. V. van Laarhoven,et al.  The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal , 2015, Cancer and Metastasis Reviews.

[22]  D. McMillan,et al.  Evaluation of a Tumor Microenvironment–Based Prognostic Score in Primary Operable Colorectal Cancer , 2014, Clinical Cancer Research.

[23]  V. Bhattacharjee,et al.  A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells , 2014, Cell cycle.

[24]  J. Alcaraz,et al.  Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts , 2015, Carcinogenesis.

[25]  J. Koo,et al.  Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer , 2015, Breast Cancer Research and Treatment.

[26]  R. DePinho,et al.  Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure. , 2014, Cancer cell.

[27]  研宙 大内田,et al.  Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions , 2005 .

[28]  S. Grivennikov,et al.  Microbiome, Inflammation, and Cancer , 2014, Cancer journal.

[29]  M. Unno,et al.  Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. , 2010, Biochemical and biophysical research communications.

[30]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[31]  A. Noske,et al.  HMGA2 gene is a promising target for ovarian cancer silencing therapy , 2008, International journal of cancer.

[32]  K. Schlingensiepen,et al.  The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-β2. , 2011, Current pharmaceutical biotechnology.

[33]  V. Shenoy,et al.  A Chemomechanical Model of Matrix and Nuclear Rigidity Regulation of Focal Adhesion Size. , 2015, Biophysical journal.

[34]  C. O'neill,et al.  Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. , 1966, Journal of cell science.

[35]  B. Geiger,et al.  Assembly and mechanosensory function of focal contacts. , 2001, Current opinion in cell biology.

[36]  Julian N. Selley,et al.  Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver , 2012, Journal of proteome research.

[37]  R. Knuechel,et al.  Tumor-associated fibroblasts (part II): Functional impact on tumor tissue. , 2002, Histology and histopathology.

[38]  G. Page,et al.  Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture , 2004, Breast Cancer Research.

[39]  R. Tollenaar,et al.  Disorganised stroma determined on pre‐treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial , 2015, Molecular oncology.

[40]  A. Ribas.  Adaptive Immune Resistance: How Cancer Protects from Immune Attack. , 2015, Cancer discovery.

[41]  S. Ghatak,et al.  Hyaluronan oligosaccharides as a potential anticancer therapeutic. , 2008, Current pharmaceutical biotechnology.

[42]  K. Nakao,et al.  Myocardin-Related Transcription Factor A Is a Common Mediator of Mechanical Stress- and Neurohumoral Stimulation-Induced Cardiac Hypertrophic Signaling Leading to Activation of Brain Natriuretic Peptide Gene Expression , 2010, Molecular and Cellular Biology.

[43]  K. Schlingensiepen,et al.  Transforming growth factor‐beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer , 2011, Cancer science.

[44]  B. Hinz,et al.  YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts. , 2015, The American journal of pathology.

[45]  D. Ingber.  Tensegrity II. How structural networks influence cellular information processing networks , 2003, Journal of Cell Science.

[46]  Helena N. Chia,et al.  Effect of substrate stiffness on pulmonary fibroblast activation by TGF-β. , 2012, Acta biomaterialia.

[47]  G. Ayala,et al.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  G. Bauer.  Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. , 1996, Histology and histopathology.

[49]  K. Illmensee,et al.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Ana M Soto,et al.  The stroma as a crucial target in rat mammary gland carcinogenesis , 2004, Journal of Cell Science.

[51]  C. Munaut,et al.  Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[52]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[53]  Prof. Theodor Langhans.  Pulsirende cavernöse Geschwulst der Milz mit metastatischen Knoten in der Leber. Tödtlicher Verlauf binnen 5 Monaten , 1879, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[54]  M. Laukkanen,et al.  Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression , 2015, Stem cells international.

[55]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[56]  D. Radisky,et al.  Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells , 2004, The Journal of cell biology.

[57]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[58]  L. Blavier,et al.  Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression , 2006, Cancer and Metastasis Reviews.

[59]  F. Couch,et al.  Loss of the Transcription Factor GLI1 Identifies a Signaling Network in the Tumor Microenvironment Mediating KRAS Oncogene-induced Transformation* , 2013, The Journal of Biological Chemistry.

[60]  Jérôme Cros,et al.  Targeting the TGFβ pathway for cancer therapy. , 2015, Pharmacology & therapeutics.

[61]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[62]  Stephen A. Sastra,et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. , 2014, Cancer cell.

[63]  C. S. Chen,et al.  Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Adam J. Engler,et al.  Matrix elasticity directs stem cell differentiation , 2006 .

[65]  Lanjing Zhang,et al.  Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis , 2015, Scientific Reports.

[66]  L Orci,et al.  Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. J. Kim,et al.  Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts , 2014, Oncogene.

[68]  Viola Vogel,et al.  Mechanotransduction involving multimodular proteins: converting force into biochemical signals. , 2006, Annual review of biophysics and biomolecular structure.

[69]  S. Carr,et al.  The extracellular matrix: Tools and insights for the "omics" era. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[70]  B. Hinz.  The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[71]  M. Bissell,et al.  Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. , 2006, Annual review of cell and developmental biology.

[72]  L. Ligon,et al.  Palladin mediates stiffness-induced fibroblast activation in the tumor microenvironment. , 2015, Biophysical journal.

[73]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[74]  P. Provero,et al.  A Mouse Stromal Response to Tumor Invasion Predicts Prostate and Breast Cancer Patient Survival , 2006, PloS one.

[75]  W. Jiang,et al.  Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes , 2014, Oncogene.

[76]  Robert P. Jenkins,et al.  Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts , 2013, Nature Cell Biology.

[77]  V. Paradis,et al.  Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients , 2015, Oncotarget.

[78]  B. Geiger,et al.  Transmembrane crosstalk between the extracellular matrix--cytoskeleton crosstalk. , 2001, Nature reviews. Molecular cell biology.

[79]  M. Zaaroor,et al.  Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study , 2010, Neuro-oncology.

[80]  H. Kosmehl,et al.  TGFβ and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin , 1995, The Histochemical Journal.

[81]  T. Wight,et al.  Hyaluronan Controls the Deposition of Fibronectin and Collagen and Modulates TGF-β1 Induction of Lung Myofibroblasts. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[82]  A. Desmoulière,et al.  Factors influencing myofibroblast differentiation during wound healing and fibrosis. , 1995, Cell biology international.

[83]  M. Barcellos-Hoff,et al.  Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.

[84]  S. Garland,et al.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. , 2006, The Journal of infectious diseases.

[85]  T. Nishiyama,et al.  Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture* , 2009, The Journal of Biological Chemistry.

[86]  H. Moses,et al.  Tumor-stroma interactions. , 2005, Current opinion in genetics & development.

[87]  A. Hall,et al.  Association of CNK1 with Rho Guanine Nucleotide Exchange Factors Controls Signaling Specificity Downstream of Rho , 2005, Current Biology.

[88]  Kenneth M. Yamada,et al.  Cell–matrix adhesion , 2007, Journal of cellular physiology.

[89]  Angela E. Leek,et al.  Increased peri-ductal collagen micro-organization may contribute to raised mammographic density , 2016, Breast Cancer Research.

[90]  M. Esteller,et al.  DNA methylation plasticity contributes to the natural history of metastasis , 2015, Cell cycle.

[91]  U. Forsum,et al.  Bacterial vaginosis – a disturbed bacterial flora and treatment enigma , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[92]  K. Eliceiri,et al.  Aligned collagen is a prognostic signature for survival in human breast carcinoma. , 2011, The American journal of pathology.

[93]  Kenneth M. Yamada,et al.  Transmembrane crosstalk between the extracellular matrix and the cytoskeleton , 2001, Nature Reviews Molecular Cell Biology.

[94]  R. Akhurst,et al.  Complexities of TGF-β Targeted Cancer Therapy , 2012, International journal of biological sciences.

[95]  B. Hinz,et al.  Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. , 2012, The American journal of pathology.

[96]  D. Ingber.  Tensegrity I. Cell structure and hierarchical systems biology , 2003, Journal of Cell Science.

[97]  M. Gardel,et al.  CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling , 2007, The Journal of cell biology.

[98]  M J Bissell,et al.  How does the extracellular matrix direct gene expression? , 1982, Journal of theoretical biology.

[99]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[100]  Matthias Chiquet,et al.  How do fibroblasts translate mechanical signals into changes in extracellular matrix production? , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[101]  Helmut Friess,et al.  The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[102]  Alissa M. Weaver,et al.  Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment , 2006, Cell.

[103]  Umar Mahmood,et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.

[104]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[105]  V. Seshan,et al.  Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. , 2008, Cancer research.

[106]  Mark W. Kieran,et al.  Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.

[107]  Luis M. Escudero,et al.  Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy , 2014, Front. Oncol..

[108]  Z. Werb,et al.  Extracellular Matrix Remodeling during Morphogenesis a , 1998, Annals of the New York Academy of Sciences.

[109]  Ben S. Wittner,et al.  Systems-Level Modeling of Cancer-Fibroblast Interaction , 2009, PloS one.

[110]  Kornelia Polyak,et al.  Microenvironmental regulation of cancer development. , 2008, Current opinion in genetics & development.

[111]  H. Shimada,et al.  Host organ specifically determines cancer progression. , 1995, Cancer research.

[112]  E. Cukierman,et al.  Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. , 2005, Seminars in cancer biology.

[113]  Thomas G. Caffery,et al.  Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer , 2008, Clinical Cancer Research.

[114]  T. Albrecht,et al.  Persistent Viral Infections , 1996 .

[115]  E. Cukierman,et al.  The wound healing, chronic fibrosis, and cancer progression triad. , 2014, Physiological genomics.

[116]  W. Shi,et al.  In Vitro Communities Derived from Oral and Gut Microbial Floras Inhibit the Growth of Bacteria of Foreign Origins , 2010, Microbial Ecology.

[117]  V. Vogel,et al.  Mesenchymal Stem Cells Exploit Extracellular Matrix as Mechanotransducer , 2013, Scientific Reports.

[118]  R. Jonsson,et al.  The Fibroblast Integrin α11β1 Is Induced in a Mechanosensitive Manner Involving Activin A and Regulates Myofibroblast Differentiation* , 2010, The Journal of Biological Chemistry.

[119]  G. Inghirami,et al.  Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.

[120]  W. Nelson,et al.  Effects of Regulated Expression of Mutant RhoA and Rac1 Small GTPases on the Development of Epithelial (MDCK) Cell Polarity , 1998, The Journal of cell biology.

[121]  J. Segars,et al.  Dynamic Reciprocity Between Cells and Their Microenvironment in Reproduction1 , 2015, Biology of reproduction.

[122]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[123]  T. Trikalinos,et al.  Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force , 2011, Annals of Internal Medicine.

[124]  E. D. de Vries,et al.  Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery. , 2001, Journal of hepatology.

[125]  R. Knuechel,et al.  Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? , 2002, Histology and histopathology.

[126]  I. Tannock,et al.  Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.

[127]  I. Mian,et al.  Tissue architecture: the ultimate regulator of breast epithelial function. , 2003, Current opinion in cell biology.

[128]  K. Credille,et al.  Nonclinical Safety Evaluation of a Transforming Growth Factor β Receptor I Kinase Inhibitor in Fischer 344 Rats and Beagle Dogs , 2014 .

[129]  Giulio Gabbiani,et al.  Mechanisms of force generation and transmission by myofibroblasts. , 2003, Current opinion in biotechnology.

[130]  P. Greenberg,et al.  Stromal reengineering to treat pancreas cancer. , 2014, Carcinogenesis.

[131]  Ricardo Garcia,et al.  Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis , 2011, Cell.

[132]  Gerald C. Chu,et al.  Stromal biology of pancreatic cancer , 2007, Journal of cellular biochemistry.

[133]  G. Watts.  MYOFIBROBLASTS , 1979, The Lancet.

[134]  Thomas Bjarnsholt,et al.  Applying insights from biofilm biology to drug development — can a new approach be developed? , 2013, Nature Reviews Drug Discovery.

[135]  B. Alman,et al.  Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation , 2014, The Journal of cell biology.

[136]  Mehrdad Mehrbod,et al.  Mechanotransduction pathways linking the extracellular matrix to the nucleus. , 2014, International review of cell and molecular biology.

[137]  David Goldstein,et al.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells. , 2008, Cancer research.

[138]  Mina J. Bissell,et al.  Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices , 2009, Cancer and Metastasis Reviews.

[139]  Matthias Chiquet,et al.  From mechanotransduction to extracellular matrix gene expression in fibroblasts. , 2009, Biochimica et biophysica acta.

[140]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[141]  Donald E Ingber,et al.  Micromechanical control of cell and tissue development: implications for tissue engineering. , 2007, Advanced drug delivery reviews.

[142]  J. Gillespie,et al.  Gene promoter methylation in prostate tumor-associated stromal cells. , 2006, Journal of the National Cancer Institute.

[143]  Viola Vogel,et al.  Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[144]  Kevin W. Eliceiri,et al.  Automated quantification of aligned collagen for human breast carcinoma prognosis , 2014, Journal of pathology informatics.

[145]  B. Hinz,et al.  The NH2-terminal peptide of α–smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo , 2002, The Journal of cell biology.

[146]  R. Hynes,et al.  Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin , 1986, Cell.

[147]  Shiladitya Sengupta,et al.  Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype , 2015, Nature Communications.

[148]  L. Coussens,et al.  Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.

[149]  J. Manson,et al.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. , 2012, Contemporary clinical trials.

[150]  R. Evans,et al.  A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response , 2013, Cell.

[151]  Paolo P. Provenzano,et al.  Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.

[152]  Sijia Zhang,et al.  The (dys)functional extracellular matrix. , 2015, Biochimica et biophysica acta.

[153]  G. Ayala,et al.  Reactive stroma in prostate cancer progression. , 2001, The Journal of urology.

[154]  Viola Vogel,et al.  Crosslinking of cell-derived 3D scaffolds up-regulates the stretching and unfolding of new extracellular matrix assembled by reseeded cells. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[155]  L. Vallières.  Trabedersen, a TGFbeta2-specific antisense oligonucleotide for the treatment of malignant gliomas and other tumors overexpressing TGFbeta2. , 2009, IDrugs : the investigational drugs journal.

[156]  A. Barbul,et al.  General principles of wound healing. , 1997, The Surgical clinics of North America.

[157]  R. Holcombe,et al.  Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer , 2016, Clinical Cancer Research.

[158]  C. Haaksma,et al.  Myocardin-Related Transcription Factors-A and -B are Key Regulators of TGF-β1-Induced Fibroblast to Myofibroblast Differentiation , 2011, The Journal of investigative dermatology.

[159]  C. Streuli,et al.  Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia , 2006, The Journal of cell biology.

[160]  C. Berking,et al.  Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil , 2003, Oncogene.

[161]  B. Toole,et al.  Hyaluronan: from extracellular glue to pericellular cue , 2004, Nature Reviews Cancer.

[162]  M. Mullendore,et al.  Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer , 2008, Gut.

[163]  D. Berger,et al.  The role of the tumor microenvironment in the progression of pancreatic cancer. , 2008, The Journal of surgical research.

[164]  D. Tarin.  Clinical and Biological Implications of the Tumor Microenvironment , 2012, Cancer Microenvironment.

[165]  A. Brandes,et al.  A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. , 2016, Neuro-oncology.

[166]  G. Wahl,et al.  Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy , 2014, Cell.

[167]  Giulio Gabbiani,et al.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.

[168]  B. Engels,et al.  Targeting stroma to treat cancers. , 2012, Seminars in cancer biology.

[169]  R. Kirsner,et al.  Dynamic reciprocity in the wound microenvironment , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[170]  H. Utsumi,et al.  Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors , 2015, Cancer Chemotherapy and Pharmacology.

[171]  K. Sekiguchi,et al.  The α4β1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[172]  Douglas B. Evans,et al.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression. , 2008, Cancer research.

[173]  B. Hinz,et al.  Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. , 2001, The American journal of pathology.

[174]  J. Baselga,et al.  Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer , 2014, Investigational New Drugs.

[175]  L. Addadi,et al.  Force and focal adhesion assembly: a close relationship studied using elastic micropatterned substrates , 2001, Nature Cell Biology.

[176]  E. Cukierman,et al.  Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. , 2015, Trends in biotechnology.

[177]  Kevin W. Eliceiri,et al.  Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage , 2009, Oncogene.

[178]  R. Eddy,et al.  Fibroblast contraction occurs on release of tension in attached collagen lattices: Dependency on an organized actin cytoskeleton and serum , 1992, The Anatomical record.

[179]  Thomas Bjarnsholt,et al.  The role of bacterial biofilms in chronic infections , 2013, APMIS. Supplementum.

[180]  Matthias Schäfer,et al.  Cancer as an overhealing wound: an old hypothesis revisited , 2008, Nature Reviews Molecular Cell Biology.

[181]  M. Barcellos-Hoff.  New Biological Insights on the Link Between Radiation Exposure and Breast Cancer Risk , 2013, Journal of Mammary Gland Biology and Neoplasia.

[182]  M J Bissell,et al.  Tissue architecture: the ultimate regulator of epithelial function? , 1998, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[183]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.